Patents Assigned to BLUEWILLOW BIOLOGICS
  • NANOEMULSION UNIVERSAL INFLUENZA VACCINE
    Publication number: 20240058434
    Abstract: The present invention relates to methods for inducing a broadly reactive immune response to multiple strains of influenza in a subject comprising intranasally administering a nanoemulsion vaccine composition comprising a computationally optimized influenza immunogen or protein.
    Type: Application
    Filed: April 11, 2023
    Publication date: February 22, 2024
    Applicant: BlueWillow Biologics, Inc.
    Inventors: Shyamala Ganeson, Vira Bitko, Ali Fattom
  • Nanoemulsion and methods of use thereof
    Patent number: 11642405
    Abstract: The present disclosure relates to compositions and methods for inducing an immune response to a composition of the invention in a subject. Additionally, the present disclosure generally relates to methods for screening for immune response to a composition of the invention.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: May 9, 2023
    Assignees: Washington University, BLUEWILLOW BIOLOGICS
    Inventors: Shabaana Abdul Khader, Mushtaq Ahmed, Ali Fattom, Douglas Smith, Tarek Hamouda
  • Persistent topical antimicrobial compositions and methods of using the same
    Patent number: 11369578
    Abstract: The present disclosure relates to nanoemulsion compositions with certain surfactant blend ratios that impart enhanced permeability. Such compositions are useful for topical, mucosal and intranasal applications and allow for the greater delivery of one or more active agents to the application site to prevent infection by a microorganism.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: June 28, 2022
    Assignee: BlueWillow Biologics, Inc.
    Inventor: Susan Ciotti
  • HERPES SIMPLEX VIRUS NANOEMULSION VACCINES AND METHODS OF USING THE SAME
    Publication number: 20220105172
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Application
    Filed: October 18, 2021
    Publication date: April 7, 2022
    Applicant: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, JR., Tarek Hamouda, Vira Bitko
  • NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
    Publication number: 20210393554
    Abstract: The present disclosure relates to nanoemulsion compositions with certain surfactant blend ratios that impart enhanced permeability. Such compositions are useful for topical, mucosal, vaginal, and intranasal applications and allow for the greater delivery of one or more active agents to the application site.
    Type: Application
    Filed: November 14, 2019
    Publication date: December 23, 2021
    Applicant: Bluewillow Biologics, Inc.
    Inventors: Susan Ciotti, David Peralta
  • Methods and compositions for nanoemulsion vaccine formulations
    Patent number: 11173197
    Abstract: The present disclosure relates to nanoemulsion vaccine compositions and methods of making and using the same. The disclosed compositions and methods provide a means of treating, preventing, or protecting an individual from anthrax exposure or poisoning.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: November 16, 2021
    Assignee: BlueWillow Biologics, Inc.
    Inventor: Susan Ciotti
  • Herpes simplex virus nanoemulsion vaccine
    Patent number: 11147869
    Abstract: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: October 19, 2021
    Assignee: BlueWillow Biologics, Inc.
    Inventors: Ali I. Fattom, Jakub Simon, James R. Baker, Jr., Tarek Hamouda, Vira Bitko
  • PERSISTANT TOPICAL ANTIMICROBIAL COMPOSITIONS AND METHODS OF USING THE SAME
    Publication number: 20210046023
    Abstract: The present disclosure relates to nanoemulsion compositions with certain surfactant blend ratios that impart enhanced permeability. Such compositions are useful for topical, mucosal and intranasal applications and allow for the greater delivery of one or more active agents to the application site to prevent infection by a microorganism.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 18, 2021
    Applicant: Bluewillow Biologics, Inc.
    Inventor: Susan Ciotti
  • PREVENTION AND TREATMENT OF CORONAVIRUS AND OTHER RESPIRATORY INFECTIONS USING NANOEMULSION COMPOSITIONS
    Publication number: 20200237689
    Abstract: The present disclosure relates to nanoemulsion compositions with certain surfactant blend ratios that impart enhanced permeability. Such compositions are useful for mucosal and intranasal applications and allow for the greater delivery of one or more active agents to the application site to prevent infection by coronavirus.
    Type: Application
    Filed: March 24, 2020
    Publication date: July 30, 2020
    Applicant: Bluewillow Biologics, Inc.
    Inventors: David Peralta, Susan Ciotti